Keefe, Bruyette & Woods analyst Kyle Voigt maintains CME Gr (NASDAQ:CME) with a Market Perform and raises the price target from $212 to $213.
Keefe, Bruyette & Woods Maintains Market Perform on CME Gr, Raises Price Target to $213
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.